Form 8-K - Current report:
SEC Accession No. 0001213900-25-010962
Filing Date
2025-02-06
Accepted
2025-02-06 16:41:09
Documents
21
Period of Report
2025-02-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0230228-8k_60degrees.htm   iXBRL 8-K 46566
2 FORM OF WARRANT ea023022801ex4-1_60degrees.htm EX-4.1 96110
3 FORM OF PLACEMENT AGENT WARRANT ea023022801ex4-2_60degrees.htm EX-4.2 94639
4 OPINION OF SICHENZIA ROSS FERENCE CARMEL LLP ea023022801ex5-1_60degrees.htm EX-5.1 10197
5 FORM OF SECURITIES PURCHASE AGREEMENT ea023022801ex10-1_60degrees.htm EX-10.1 252900
6 PRESS RELEASE, DATED FEBRUARY 5, 2025 ea023022801ex99-1_60degrees.htm EX-99.1 13659
7 PRESS RELEASE, DATED FEBRUARY 6, 2025 ea023022801ex99-2_60degrees.htm EX-99.2 14176
8 GRAPHIC ex5-1_001.jpg GRAPHIC 7810
  Complete submission text file 0001213900-25-010962.txt   894273

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE sxtp-20250205.xsd EX-101.SCH 3813
10 XBRL DEFINITION FILE sxtp-20250205_def.xml EX-101.DEF 26668
11 XBRL LABEL FILE sxtp-20250205_lab.xml EX-101.LAB 36762
12 XBRL PRESENTATION FILE sxtp-20250205_pre.xml EX-101.PRE 25292
24 EXTRACTED XBRL INSTANCE DOCUMENT ea0230228-8k_60degrees_htm.xml XML 5793
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

EIN.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41719 | Film No.: 25597993
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)